Go here to see the original: Hepion Pharmaceuticals Schedules Conference Call to Review Additional Efficacy Data from Phase 2 ‘ALTITUDE-NASH’ Liver Function Trial of...
Go here to see the original: Hepion Pharmaceuticals Schedules Conference Call to Review Additional Efficacy Data from Phase 2 ‘ALTITUDE-NASH’ Liver Function Trial of...
Read the original here: Altamira Therapeutics Announces European Patent Office Decision to Grant for Patent Application Covering Intranasal Betahistine
Original post: Pharming Group provides updates on EMA regulatory review of leniolisib MAA and plans to file for UK regulatory approval
See the rest here: Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum
Excerpt from: Akero Therapeutics to Present Late-Breaking Oral and Poster Presentations on EFX at AASLD’s The Liver Meeting® 2023
Go here to see the original: SciSparc Aims to Change Tourette Syndrome Treatments; Will Start a Phase IIb Trial with its Innovative Pharma-Grade THC-Based Medication
Link: STADA and Alvotech receive positive CHMP opinion for Europe’s first ustekinumab biosimilar to Stelara
Excerpt from: Lexicon Pharmaceuticals to Participate in the Jefferies London Healthcare Conference
The rest is here: Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
See the original post: Long-term Survival Data from Longeveron’s ELPIS 1 Trial Presented at the 2023 Scientific Sessions of the American Heart Association
Recent Comments